Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Anti-Mullerian hormone levels in girls and adolescents with Turner syndrome are related to karyotype, pubertal development and growth hormone treatment

28 Mar 2013

Abstract excerpt

STUDY QUESTION: In girls and adolescents with Turner syndrome (TS), is there a correlation between serum AMH levels and karyotype, spontaneous puberty and other biochemical markers of ovarian function, or growth hormone (GH) therapy? SUMMARY ANSWER: Serum anti-Müllerian hormone (AMH) correlates with karyotype, pubertal development, LH, FSH and are measurable in a higher percentage of TS patients under GH therapy....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
Share to Gynecological conditions and treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Ovarian function and disorders

Source

Identifiers

PMID: 23539612
DOI: 10.1093/humrep/det089

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Anti-Mullerian hormone levels in girls and adolescents with Turner syndrome are related to karyotype, pubertal development and growth hormone treatmentPMID 23539612Read ↗

Anti-Müllerian hormone levels in patients with turner syndrome: Relation to karyotype, spontaneous puberty, and replacement therapy.Semantic proximity Read ↗

Serum Levels of Anti-Müllerian Hormone as a Marker of Ovarian Function in 926 Healthy Females from Birth to Adulthood and in 172 Turner Syndrome PatientsSemantic proximity Read ↗

AMH and other markers of ovarian function in patients with Turner syndrome – a single center experience of transition from pediatric to gynecological follow upSemantic proximity Read ↗

FSH, LH, inhibin B and estradiol levels in Turner syndrome depend on age and karyotype: longitudinal study of 70 Turner girls with or without spontaneous pubertySemantic proximity Read ↗

Karyotype-phenotype associations in turner syndrome: a multicenter retrospective cohort study.Semantic proximity Read ↗

Why Treat girls with Turner Syndrome with Growth Hormone? Growth and Beyond.Semantic proximity Read ↗

Navigating fertility dilemmas across the lifespan in girls with Turner syndrome—a scoping reviewSemantic proximity Read ↗

Anti-Müllerian Hormone Level Determinants among Non-Polycystic-Ovary-Syndrome Women Undergoing In Vitro Fertilization: A Retrospective Cross-Sectional StudySemantic proximity Read ↗

What Does AMH Tell Us in Pediatric Disorders of Sex Development?Semantic proximity Read ↗

[Turner Syndrome: what's new in medical care?].Semantic proximity Read ↗

Anti-Müllerian hormone: a new actor of sexual dimorphism in pituitary gonadotrope activity before pubertySemantic proximity Read ↗

Epidemiological, endocrine and metabolic features in Turner syndromeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.